US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Biotech Top 5 Bull 2X ETF

39.29

-0.3198-0.81%

Post-market: 39.610.3198+0.81%16:10 EDT

Volume:158

Turnover:6K

Market Cap:2.95M

PE:- -

High:39.29

Open:39.61

Low:39.29

Close:39.61

52wk High:45.88

52wk Low:25.71

Shares:75.00K

Float Shares:75.00K

Volume Ratio:0.02

T/O Rate:0.21%

Dividend:0.62

Dividend Rate:1.58%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Gilead - Expands Six Royalty-Free Voluntary Licensing Agreements for Once-Yearly Lenacapavir for Hiv Prevention

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Ascendis Pharma (ASND) and Charles River Labs (CRL)

The 'CIA' Strategy Beating the Market: How One Top-Performing Money Manager Spots Mispriced Stocks.

Sling Therapeutics Raises $123 Million to Advance Thyroid Eye Disease Drug

Rohto Starts Phase II Trial of RE-01 Cell Therapy for Refractory Ischemic Leg Ulcers

Bristol Myers Sues Amgen over Proposed Opdivo Biosimilar

ASX biotech expands diagnostics portfolio after FDA approval

Morning Star AU

Gilead Sciences Expands Lenacapavir Access to 14 Countries

MT Newswires Live

Gilead announces agreement with PAHO for lenacapavir access

Gilead: Explores Opportunities with Brazilian Health Ministry to Advance Ministry’s Goal of Enabling Local Production of Lenacapavir

THOMSON REUTERS

Gilead: Agreement Establishes Regional Pathway Through Pan American Health Organization's Regional Revolving Funds

THOMSON REUTERS

Gilead: Co & Paho Announce Partnership to Accelerate Access to Twice-Yearly Lenacapavir for Hiv Prevention Across Latin America & Caribbean

THOMSON REUTERS

Gilead, PAHO Agree on HIV Prevention Drug Access in Latin America, Caribbean

Gilead: to Continue Exploring Opportunities to Work with Paho to Support Country Readiness & Scale-up of Long-Acting Hiv Prevention Access

THOMSON REUTERS

Gilead Exec Says Weekly Oral Hiv Prevention Drug Expected to Launch in First Quarter of 2027 - Conf Call

THOMSON REUTERS

Gilead Exec Says Hiv Market Growth Should Normalize to 2%-3% Within Next Couple of Quarters - Conf Call

THOMSON REUTERS

Amgen Announces Dividend of R$ 0.31 Per Unit, Payable Sept. 17

Press Release: Legend Biotech Appoints Ingrid Zhang as Chief Executive Officer

Vertex Pharmaceuticals partners with Lindsey Vonn for JOURNAVX awareness

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Centene (CNC), Natera (NTRA) and Vertex Pharmaceuticals (VRTX)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/TBXU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TBXU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","market":"US","secType":"STK","nameCN":"Direxion Daily Biotech Top 5 Bull 2X ETF","latestPrice":39.2938,"timestamp":1789761600000,"preClose":39.6136,"halted":0,"volume":158,"hourTrading":{"tag":"盘后","latestPrice":39.6136,"preClose":39.2938,"latestTime":"16:10 EDT","volume":6,"amount":236.2752,"timestamp":1789762204291,"change":0.3198,"changeRate":0.008139,"amplitude":0},"delay":0,"changeRate":-0.008072985035442393,"floatShares":75001,"shares":75001,"eps":0,"marketStatus":"Market Closed","change":-0.3198,"latestTime":"09-18 16:00:00 EDT","open":39.6136,"high":39.2938,"low":39.2938,"amount":6307,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":39.6136,"sharesOutstanding":100001,"nav":39.619,"aum":2971444.91,"dividendRate":0.015824,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":39.6136,"preClose":39.2938,"latestTime":"16:10 EDT","volume":6,"amount":236.2752,"timestamp":1789762204291,"change":0.3198,"changeRate":0.008139,"amplitude":0},"volumeRatio":0.017816468110135715},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","floatShares":75001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.017816468110135715,"shares":75001,"dividePrice":0.6218,"high":39.2938,"amplitude":0,"preClose":39.6136,"low":39.2938,"week52Low":25.71,"pbRate":"--","week52High":45.88,"institutionHeld":0,"latestPrice":39.2938,"eps":0,"divideRate":0.015824,"volume":158,"delay":0,"ttmEps":0,"open":39.6136,"prevYearClose":31.065,"prevWeekClose":38.3601,"prevMonthClose":42.9245,"prevQuarterClose":32.1223,"fiveDayClose":38.3601,"twentyDayClose":43.3255,"sixtyDayClose":30.1137},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TBXU\",params:#limit:5,,,undefined,":[{"date":"2026-06-23","symbol":"TBXU","amount":0.11101,"announcedDate":"2026-06-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-23","defaultRemindTime":1782221400000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-23","currency":"USD","dateTimestamp":1782187200000,"payDate":"2026-06-30"},{"date":"2026-03-24","symbol":"TBXU","amount":0.09893,"announcedDate":"2026-03-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-24","defaultRemindTime":1774359000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-24","currency":"USD","dateTimestamp":1774324800000,"payDate":"2026-03-31"},{"date":"2025-12-23","symbol":"TBXU","amount":0.10111,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-31"},{"date":"2025-12-10","symbol":"TBXU","amount":0.31143,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-17","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TBXU\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-17","value":0.31143,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-31","value":0.10111,"currency":"USD"},{"executeDate":"2026-03-24","recordDate":"2026-03-24","paymentDate":"2026-03-31","value":0.09893,"currency":"USD"},{"executeDate":"2026-06-23","recordDate":"2026-06-23","paymentDate":"2026-06-30","value":0.11101,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TBXU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TBXU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667983112","title":"Gilead - Expands Six Royalty-Free Voluntary Licensing Agreements for Once-Yearly Lenacapavir for Hiv Prevention","url":"https://stock-news.laohu8.com/highlight/detail?id=2667983112","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667983112?lang=en_us&edition=fundamental","pubTime":"2026-09-16 20:30","pubTimestamp":1789561801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nTUA4XXCG2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","LU1934455277.USD","LU2324357040.USD","LU0058720904.USD","LU2112291526.USD","IE00B3T34201.USD","IE00B19Z3581.USD","LU0882574055.USD","IBBQ","LU0861579265.USD","IE00BZ1G4Q59.USD","IE00B7SZLL34.SGD","SG9999015952.SGD","SG9999015945.SGD","LU0122379950.USD","LU1066053197.SGD","IE00BKVL7J92.USD","TBXU","LU1934455863.HKD","LU2357627491.SGD","LU0234570918.USD","LU0109394709.USD","LU0965509101.SGD","TMED","LU1571399168.USD","LU1061106388.HKD","GILD","IE00BSNM7G36.USD","LU0114720955.EUR","LU0965509283.SGD","LU1057294990.SGD","LU1037948897.HKD","IBB","SG9999015978.USD","LU0823416689.USD","LU1037948541.HKD","BIB","LU1023059063.AUD","LU0859254822.USD","BBH","LU2089984988.USD","LU1585245621.USD","LU1839511570.USD","BK4550","BK4566","LU0965509010.AUD","LU2087621335.USD","MEDI","BMED","LU1430594728.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667979600","title":"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Ascendis Pharma (ASND) and Charles River Labs (CRL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667979600","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667979600?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:20","pubTimestamp":1789557614,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vertex Pharmaceuticals (VRTX), Ascendis Pharma (ASND...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-ascendis-pharma-asnd-and-charles-river-labs-crl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-ascendis-pharma-asnd-and-charles-river-labs-crl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBH","LABU","LU2324357040.USD","CRL","LU2237438978.USD","LU2417539215.USD","MEDI","LU2462157665.USD","IE0009355771.USD","LU2236285917.USD","LU0061475181.USD","LU0889565916.HKD","LU0289739699.SGD","BK4588","BK4585","LU0029874061.USD","LU1674673428.USD","IE00BZ9MQY76.HKD","VERX","BK4023","IBBQ","LU1093756168.USD","LU0390134368.USD","LU2362540622.SGD","LU1778281490.HKD","ASND","LU0109394709.USD","BK4581","LU1035775433.USD","IE00B894F039.SGD","IE00BJJMRZ35.SGD","TBXU","XBI","SGXZ57979304.SGD","XLV","GNMX","BIB","HCSG","LU1559883803.SGD","LU1585245621.USD","LU2362541273.HKD","VRTX","LU1430594728.SGD","BK4533","LU0757428866.USD","PBE","IBB","IDNA","LU1069344957.HKD","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667600950","title":"The 'CIA' Strategy Beating the Market: How One Top-Performing Money Manager Spots Mispriced Stocks.","url":"https://stock-news.laohu8.com/highlight/detail?id=2667600950","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667600950?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:20","pubTimestamp":1789557600,"startTime":"0","endTime":"0","summary":"T. Rowe Price manager looks for trouble to find his global value betsT.Rowe Price manager Sebastien Mallet is betting on more than technology for his five-star fund.One secret to global value manager Sebastien Mallet's success?","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0208291251.USD","DRIV","LU2148611432.USD","LU0048584097.USD","LU1934455277.USD","LU1232071149.USD","VFH","BK4022","LU1037948897.HKD","AMDU","IE000WAW04H5.SGD","LU1951198990.SGD","UYG","LU1551013425.SGD","BK4534","LU0345770308.USD","IE00BWXC8680.SGD","SKHL","LU2168564222.USD","LU0170899867.USD","INTC","TRUF","LU1064131342.USD","LU1829250122.USD","LU1236620750.USD","LU0127658192.USD","IE00BQXX3F31.USD","LEGR","LU0203347892.USD","LU1043141396.HKD","LU0198837287.USD","LU1803068979.SGD","LU0820561909.HKD","TRFK","LU0256863811.USD","LU2720916845.USD","TBXU","LU0820562030.AUD","IE000F7OJYX1.SGD","LU0203345920.USD","LU0215105999.USD","LU1267930813.SGD","FMTL","IE000M9KFDE8.USD","LU1917777945.USD","LU2471134523.USD","LU0942090050.USD","LU1861220033.SGD","SKDD","LU0976567544.SGD","IE00B775SV38.USD","JPMO","ILDR","LU0211326839.USD","LU0557290698.USD","LU0889565916.HKD","IE0004445239.USD","SG9999001424.SGD","PSI","BK4543","LU0234570918.USD","LU2764263203.CNY","LU2361044865.SGD","BK4520","LU2552382132.HKD","IE00B19Z3B42.SGD","LU2896262040.SGD","07709","LU2098885051.SGD","LU2244417387.USD","SG9999015978.USD","LU2361044949.HKD","LU0640476718.USD","BK4232","LU0345769128.USD","IE00BMPRXR70.SGD","BK4515","LU2931357623.SGD","LU0390134368.USD","IE00BQXX3D17.EUR","LU1242518857.USD","LU2756315318.SGD","BK4579","HK0000304797.USD","LU0612318971.USD","LU2097829019.USD","TTEQ","LU0109392836.USD","IE00B1BXHZ80.USD","INTW","LU0979878070.USD","LU2764263039.SGD","BK4588","LU1496350171.SGD","IE00BN8TJ469.HKD","SK","BBH","FNV","IE00BSNM7G36.USD","LU0157215616.USD","LU2023250330.USD","LU0114720955.EUR","LU1430594728.SGD","LU0345770993.USD","LU0786609619.USD","LU2430703095.HKD","LU2237443465.HKD","LU2756315664.SGD","LU2054465674.USD","LU2089984988.USD","LU0081259029.USD","LU2471134879.HKD","SG9999002232.USD","LU0889565833.HKD","LU0708994859.HKD","LU1989772923.USD","LU2381873111.SGD","LU0432979614.USD","AMUU","BK4585","LU1861559042.SGD","IE000MB6IJN5.SGD","IE00BMPRXQ63.HKD","LU1914381329.SGD","SILJ","KBWB","LU2417539215.USD","LU2237957902.USD","LU0426417589.USD","SG9999015952.SGD","LU0097036916.USD","LU0823421333.USD","IE0002270589.USD","LU0868494708.USD","LU2213496289.HKD","BK4529","LU1244550221.USD","LU0345769631.USD","LU2360107168.USD","HK0000304805.HKD","LU0029864427.USD","LU1571399168.USD","SGXZ81514606.USD","LU0256863902.USD","LU0742534661.SGD","LU0792757196.USD","IE0034235188.USD","BK4532","LU2430703178.SGD","GAMR","LU1720051108.HKD","LU2764262908.HKD","IE00BJLML261.HKD","LU1894683348.USD","SAMD0main","LU2471134796.USD","LU2461242641.AUD","LU2456880835.USD","IE00B7SZLL34.SGD","LU0122379950.USD","BK4578","SIL","IE0001KFT4U8.USD","SMHX","BK4550","LU0965509283.SGD","AMDW","FNCL","FAI","IBB","LU2860962120.EUR","LU2023250843.SGD","LU2592432038.USD","BK4573","IE00BK4W5L77.USD","LU0310799852.SGD","LU2265009873.SGD","LU1023059063.AUD","IE00BJTD4N35.SGD","LU0251132253.USD","QQQA","AMYY","AZNH","BK4566","AIS","BKNU","LU0149725797.USD","LU0320765992.SGD","LU1244550577.SGD","BK4605","IE00B1XK9C88.USD","LU0965509010.AUD","BK4612","LU0234572021.USD","LU1668664300.SGD","LU2290526834.HKD","IBBQ","LU1496350502.SGD","IE00BYXW3230.USD","LU1267930490.SGD","LU1674673691.USD","AMDG","LU0048573561.USD","LU1934455194.USD","SLVR","LU0823416689.USD","LU0106261372.USD","IE00BDRTCR15.USD","LU2237957811.SGD","LU1852331112.SGD","IE00B19Z3581.USD","LU1043141123.HKD","LU1894683264.USD","AMDY","LU0353189763.USD","LU2505996681.GBP","LU2089985449.USD","LU0964807845.USD","BK4139","LU0320765646.SGD","IE00B3T34201.USD","LU1150488218.USD","JPM","LU1316542783.SGD","MEDI","SG9999004303.SGD","LU0321505868.SGD","BK4567","LU1261432733.SGD","IE00BLSP4239.USD","LU2462591350.SGD","LU1699723380.USD","BMED","LU2242649171.HKD","LU2250418816.HKD","LU2471134952.CNY","SG9999015945.SGD","AIQ","LU0323591593.USD","LU1585245621.USD","IE00BDCRKT87.USD","LU0265550946.USD","LU2108987350.USD","LU0225283273.USD","LU2087625088.SGD","AMDD","XLF","JBHT","LU0654597011.USD","LU1674673428.USD","LU0265550359.USD","LU0971096721.USD","IE0034235303.USD","SINTCmain","LU0210536198.USD","LU0320765489.SGD","LU1032466523.USD","LU1880398471.USD","LU2543165471.USD","LU1551013342.USD","LU0787776722.HKD","LU2168564065.EUR","IYG","BK4207","IE00BK4W5M84.HKD","JPO","LU0882574055.USD","LU2264538146.SGD","LU1629891620.HKD","LU0823421416.USD","LU1084165304.USD","CHAT","LU1989764748.USD","LU0994945656.USD","IE00BFXG1179.USD","LU0006306889.USD","FTXL","LU1267930573.SGD","LU1280957306.USD","LU2357627491.SGD","LU0943347566.SGD","IE00BQXX3C00.GBP","AWAY","BK4602","BK4581","LU2746668974.SGD","IE00BKDWB100.SGD","LU1150488135.SGD","LU2023250504.SGD","BK4527","WUGI","IE0000B7K699.USD","USXF","WISE","SG9999015986.USD","LU0082616367.USD","LU0056508442.USD","LU1430597077.USD","LU2237443549.SGD","LU0823413587.USD","LU1951200564.SGD","LU0174119429.USD","LU1242518931.SGD","LU2236285917.USD","LU0823397285.USD","LU0267386448.USD","LU2468319806.SGD","LU1066053197.SGD","LU0077335932.USD","LU0820561818.USD","BAI","LU2168564149.EUR","LU0345774391.USD","LU1861215975.USD","LU1366333091.USD","BK4548","LU0882574139.USD","LU1670627923.USD","HYNX","LU0211328371.USD","LU2008162690.USD","IE00BHPRN162.USD","LU0106831901.USD","AMDL","BK4535","LU0689472784.USD","LU1119994496.HKD","LU1989764664.SGD","BK4614","LU0251142724.SGD","IYF","LU2168563687.JPY","LU0859254822.USD","BK4142","LU0426412945.USD","LU1880398554.USD","LU0683600562.USD","WPM","AMDS","IE0009356076.USD","IE0034235295.USD","LU0109394709.USD","LU2746668461.USD","LU2087621335.USD","LU1236620834.HKD","TFNS","LU0861579265.USD","LU0823413660.USD","IE00BBT3K403.USD","AMDC","LU2106854487.HKD","LU2211815571.USD","IE00B5TLWC47.USD","DAMD","LU0238689110.USD","LU0316494557.USD","CHPS","SOXX","LU1061106388.HKD","SGXZ99366536.SGD","BK4533","LU1303367103.USD","LU0353189680.USD","LINT","LU0345774631.USD","XNTK","SG9999002224.SGD","LU1956131251.USD","LU2355687059.USD","SG9999001440.SGD","TMED","IE00BKVL7J92.USD","INYY","INT","AUAU","LU1366192091.USD","SKHQ","IE000SO60NU8.SGD","LU0133085943.USD","LU1121112475.USD","LU2237443978.SGD","ARTY","LU1548497426.USD","LU0251131958.USD","LU1934455863.HKD","BK4575","LU1804176565.USD","LU2462157665.USD","LU0496365809.HKD","LU1989772840.SGD","LU2237443382.USD","IE00BJTD4V19.USD","LU0719512351.SGD","LU2430703251.USD","LU0823434740.USD","LU0310800379.SGD","SKUU","04335","LU0321505439.SGD","FTXO","LU0266013472.USD","LU2361045086.USD","TEK","LU1778281490.HKD","LU2552382058.USD","SMH","LU0211331839.USD","BK4583","LU2360106780.USD","LU2324357040.USD","BK4554","LU1116320901.HKD","BK4568","IE00B5949003.HKD","LU1145028129.USD","LU1670628061.USD","IE00B3S45H60.SGD","LU2750360997.AUD","SKHN","BIB","IXG","AZN","LU1057294990.SGD","LU1363072403.SGD","SKHU","SOXY","BK4512","IETC","LU0058720904.USD","LU2357305700.SGD","LU0289739699.SGD","GLDN","GOAU","LU0965508806.USD","BKNG","LU0128525929.USD","LU2552382215.SGD","LU0612318385.USD","LU0211327993.USD","LU1923623000.USD","LU0642271901.SGD","SKHY","SGXZ23171101.USD","BK4135","BK4561","LU1066051498.USD","TROW","BK4141","LU1244550494.USD","LU0154236417.USD","LU0965509101.SGD","CNAV","LU0823434583.USD","IE00BLSP4452.SGD","AMD","LU0187121727.USD","LU0417517546.SGD","SKHYV","LU1861558580.USD","BK4504","BK4516","LU0274383776.USD","LU0823411888.USD","SKHX","SGXZ51526630.SGD","LU1116320737.USD","LU0070302665.USD","LU2112291526.USD","BK4007","SKHA","LU1974910355.USD","LU2750360641.GBP","GDX","LU1839511570.USD","LU0889566641.SGD","LU2458330169.SGD","LU0211326755.USD","LU2237443622.USD","GILD","LU2177674079.SGD","LU1162221912.USD","LU2168564495.EUR","LU0868494617.USD","LU2505996509.AUD","IE000BZT7R73.USD","LU0823397103.USD","LU2247934214.USD","BK4017","LU1988902786.USD","SKHZ","LU2237443895.HKD","LU2458330243.SGD","IE00BMPRXN33.USD","WNDR","LU1037948541.HKD","LU1720051017.SGD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667607925","title":"Sling Therapeutics Raises $123 Million to Advance Thyroid Eye Disease Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2667607925","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667607925?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:00","pubTimestamp":1789556400,"startTime":"0","endTime":"0","summary":"Sling Therapeutics raises $123 million to advance thyroid eye disease drugSept 16 (Reuters)-Drug developer Sling Therapeutics said on Wednesday ithad raised $123 million to advance a late-stage trial ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nL4N457178:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4R5TH58.HKD","BK4581","LU0889565916.HKD","LU1061106388.HKD","IE00BFTCPJ56.SGD","AMGN","IE0009355771.USD","VRDN","BK4534","LU2242646821.SGD","LU1023059063.AUD","IE0002141913.USD","SG9999001440.SGD","LU0122379950.USD","IBBQ","BK4566","BK4585","BK4139","BIB","IBB","BK4599","LU2242652126.USD","LU1057294990.SGD","BK4588","IE00B2B36J28.USD","LU2089984988.USD","LU1571399168.USD","IE00BJJMRZ35.SGD","LU2112291526.USD","LU2468319806.SGD","LU0109394709.USD","PBE","LU0320765992.SGD","BK4533","IE00BJT1NW94.SGD","LU0058720904.USD","LU1983299246.USD","BBH","LU0868494617.USD","TBXU","PJP","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667832674","title":"Rohto Starts Phase II Trial of RE-01 Cell Therapy for Refractory Ischemic Leg Ulcers","url":"https://stock-news.laohu8.com/highlight/detail?id=2667832674","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667832674?lang=en_us&edition=fundamental","pubTime":"2026-09-16 11:47","pubTimestamp":1789530442,"startTime":"0","endTime":"0","summary":"Rohto starts Phase II trial of RE-01 cell therapy for refractory ischemic leg ulcersRohto began CDMO manufacturing for RE-01 cell therapy used in a Phase II investigator-led trial for refractory ische","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDLJMrSH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","SG9999015978.USD","LU1066053197.SGD","LU0122379950.USD","LU0320765992.SGD","LU1778281490.HKD","SG9999015945.SGD","LU1037948541.HKD","GILD","LU2468319806.SGD","LU0114720955.EUR","IE00BKVL7J92.USD","TBXU","LU0861579265.USD","LU1430594728.SGD","LU0965509283.SGD","BBH","LU2087621335.USD","LU0289739699.SGD","IBB","LU0823416689.USD","LU1037948897.HKD","LU1934455194.USD","BK4583","LU1057294990.SGD","BK4568","LU2112291526.USD","SG9999015986.USD","BIB","LU1934455277.USD","LU0965509010.AUD","IE00BZ1G4Q59.USD","LU1839511570.USD","BK4550","LU1674673691.USD","LU2089984988.USD","LU1066051498.USD","MEDI","LU1585245621.USD","TMED","IE00B7SZLL34.SGD","BMED","LU1061106388.HKD","BK4578","IBBQ","LU0889565916.HKD","LU0234570918.USD","LU2357627491.SGD","LU1934455863.HKD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667624218","title":"Bristol Myers Sues Amgen over Proposed Opdivo Biosimilar","url":"https://stock-news.laohu8.com/highlight/detail?id=2667624218","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667624218?lang=en_us&edition=fundamental","pubTime":"2026-09-16 04:25","pubTimestamp":1789503924,"startTime":"0","endTime":"0","summary":"UPDATE 1-Bristol Myers sues Amgen over proposed Opdivo biosimilarSept 15 (Reuters)-Bristol Myers SquibbBMY.Nand Ono Pharmaceutical4528.Thave sued AmgenAMGN.Oin Delaware federal court, seeking to block","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL6N457192:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0122379950.USD","BK4599","IE0002141913.USD","LU2242646821.SGD","LU1571399168.USD","BIB","BBH","LU0985481810.HKD","LU2089984988.USD","LU2242652126.USD","LU1061106388.HKD","LU1291159041.SGD","04332","BK4139","LU0321505868.SGD","LU1868836757.USD","AMGN","IHE","LU1032466523.USD","IE00BFTCPJ56.SGD","LU0868494617.USD","LU0306807586.USD","LU1868836914.USD","LU1989771016.USD","LU1670710588.SGD","BK4534","PJP","BK4566","LU1093756325.SGD","LU1236620750.USD","LU2125154778.USD","IBBQ","LU0225771236.USD","LU0114720955.EUR","LU1983299246.USD","LU0058720904.USD","LU1868837136.USD","LU0096364046.USD","LU1585245621.USD","LU2360032135.SGD","BK4533","BK4532","IE0009355771.USD","LU1074936037.SGD","IE00BFXG1179.USD","IE00BJJMRZ35.SGD","LU0109394709.USD","TBXU","LU1670711040.USD","LU0432979614.USD","LU0456855351.SGD","LU0061475181.USD","LU1883839398.USD","SG9999001440.SGD","LU2596442595.SGD","LU0882574055.USD","LU2125154935.USD","LU0889565916.HKD","BK4007","LU2468319806.SGD","LU1057294990.SGD","LU0289739699.SGD","LU1261432733.SGD","BK4559","LU1868837300.USD","LU1323610961.USD","LU0320765992.SGD","LU0225284248.USD","PBE","IE00B4R5TH58.HKD","LU1670711123.USD","LU1718418525.SGD","LU2112291526.USD","LU0321505439.SGD","LU2133065610.SGD","LU0267386448.USD","LU1430594728.SGD","LU0306806265.USD","IE00B2B36J28.USD","BMY","BK4588","LU1236620834.HKD","IE00BSNM7G36.USD","FTXH","LU0237698245.USD","IBB","IE00BJT1NW94.SGD","BK4585","LU1670710661.SGD","LU1023059063.AUD","BK4581","LU1093756168.USD","LU1868836591.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667671746","title":"ASX biotech expands diagnostics portfolio after FDA approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2667671746","media":"Morning Star AU","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667671746?lang=en_us&edition=fundamental","pubTime":"2026-09-16 00:00","pubTimestamp":1789488000,"startTime":"0","endTime":"0","summary":"Telix Pharmaceutical’s (ASX.TLX) Pixclara becomes the first positron emission tomography, or PET, imaging agent for glioma brain cancer to receive approval from the US Food and Drug Administration.Why","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"morningstar_stock","url":"https://www.morningstar.com.au/stocks/asx-biotech-expands-diagnostics-portfolio-after-fda-approval","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.morningstar.com.au/stocks/asx-biotech-expands-diagnostics-portfolio-after-fda-approval","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"morningstar_stock","symbols":["NVIB","TECB","BMED","IBB","MRNX","MRNY","IDNA","BK4588","LABU","LFSC","PINK","BBP","GNMX","TBXU","GDOC","IYH","BK4585","SYNB","PSCH","XLVX","FRTY","RSPH","MEDI","IEIH","XBIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667490625","title":"Gilead Sciences Expands Lenacapavir Access to 14 Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2667490625","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667490625?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:43","pubTimestamp":1789487029,"startTime":"0","endTime":"0","summary":"Gilead Sciences  said Tuesday it entered into an agreement with the Pan American Health Organization to expand access to twice-yearly lenacapavir as pre-exposure prophylaxis for HIV prevention.The agreement creates a new access pathway for 14 PAHO member states in Latin America and the Caribbean outside existing voluntary licensing agreements, complementing generic access efforts across the region, the company said.The countries are Argentina, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Guatemala, Mexico, Panama, Paraguay, Peru, Uruguay and Venezuela, Gilead said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0058720904.USD","LU0320765992.SGD","LU1934455863.HKD","TBXU","IE00BKVL7J92.USD","LU0859254822.USD","LU0109394709.USD","LU1023059063.AUD","LU1934455277.USD","SG9999015952.SGD","BIB","BK4568","LU1778281490.HKD","BK4585","LU0965509010.AUD","IE00B19Z3581.USD","LU0114720955.EUR","IE0002270589.USD","LU0234570918.USD","BK4588","LU0965508806.USD","LU2112291526.USD","LU1037948541.HKD","BMED","BK4566","IE00B19Z3B42.SGD","LU1571399168.USD","LU0965509283.SGD","LU1674673691.USD","IBB","GILD","LU0882574055.USD","LU1037948897.HKD","LU1430594728.SGD","MEDI","TMED","SG9999015986.USD","IE00B3T34201.USD","LU1674673428.USD","BBH","LU0861579265.USD","IE00B7SZLL34.SGD","LU1061106388.HKD","IE00BZ1G4Q59.USD","LU2324357040.USD","BK4550","LU0122379950.USD","LU0823416689.USD","IBBQ","LU1839511570.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667625575","title":"Gilead announces agreement with PAHO for lenacapavir access","url":"https://stock-news.laohu8.com/highlight/detail?id=2667625575","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667625575?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:15","pubTimestamp":1789485318,"startTime":"0","endTime":"0","summary":"Gilead (GILD) Sciences announced a new agreement with the Pan American Health Organization, or PAHO, to accelerate access to twice-yearly lenacapav...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gilead-announces-agreement-with-paho-for-lenacapavir-access-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gilead-announces-agreement-with-paho-for-lenacapavir-access-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0882574055.USD","LU1066051498.USD","LU2089984988.USD","LU0965509283.SGD","LU1061106388.HKD","TBXU","IE0002270589.USD","GILD","LU0058720904.USD","IBB","LU0289739699.SGD","TMED","BK4585","SG9999015945.SGD","IBBQ","IE00B7SZLL34.SGD","LU1037948897.HKD","LU1585245621.USD","LU0859254822.USD","LU1037948541.HKD","LU0114720955.EUR","LU1934455863.HKD","SG9999015952.SGD","LU1430594728.SGD","BK4566","LU1066053197.SGD","BK4583","LU1571399168.USD","LU2324357040.USD","BK4568","SG9999015986.USD","BK4532","LU0234570918.USD","LU0861579265.USD","BIB","BK4550","LU1674673428.USD","LU1778281490.HKD","MEDI","LU1023059063.AUD","BK4578","LU0965509010.AUD","BBH","BK4588","BMED","LU1674673691.USD","LU0965509101.SGD","IE00B3T34201.USD","LU2468319806.SGD","LU1839511570.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667623063","title":"Gilead: Explores Opportunities with Brazilian Health Ministry to Advance Ministry’s Goal of Enabling Local Production of Lenacapavir","url":"https://stock-news.laohu8.com/highlight/detail?id=2667623063","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667623063?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nP8N3M60G8:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1037948897.HKD","LU1778281490.HKD","BK4583","LU1057294990.SGD","LU0882574055.USD","LU0859254822.USD","LU1674673691.USD","LU0109394709.USD","LU2468319806.SGD","IE00BKVL7J92.USD","IBB","LU0234570918.USD","LU1571399168.USD","IE00B19Z3581.USD","LU0965509283.SGD","SG9999015952.SGD","BMED","IE00B19Z3B42.SGD","BBH","SG9999015986.USD","BK4532","LU1934455277.USD","IE00B7SZLL34.SGD","LU0058720904.USD","BK4578","LU1839511570.USD","LU2357627491.SGD","LU0861579265.USD","MEDI","LU2324357040.USD","SG9999015945.SGD","IE00B3T34201.USD","GILD","LU1430594728.SGD","LU1585245621.USD","SG9999015978.USD","LU0823416689.USD","LU2089984988.USD","TBXU","LU1037948541.HKD","LU1061106388.HKD","TMED","BK4566","IE0002270589.USD","LU0889565916.HKD","LU0965509010.AUD","LU1066053197.SGD","IE00BSNM7G36.USD","IBBQ","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667623061","title":"Gilead: Agreement Establishes Regional Pathway Through Pan American Health Organization's Regional Revolving Funds","url":"https://stock-news.laohu8.com/highlight/detail?id=2667623061","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667623061?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nP8N3M60G8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BBH","LU1066053197.SGD","LU1934455277.USD","LU1571399168.USD","SG9999015945.SGD","LU0965509010.AUD","IBB","BK4585","IE0002270589.USD","LU1778281490.HKD","LU1057294990.SGD","LU2468319806.SGD","LU1061106388.HKD","MEDI","LU0114720955.EUR","BK4139","BMED","LU0965509101.SGD","TMED","BK4568","LU1066051498.USD","TBXU","LU0965508806.USD","SG9999015952.SGD","LU0289739699.SGD","IBBQ","LU0859254822.USD","GILD","IE00BKVL7J92.USD","BK4550","LU0058720904.USD","SG9999015986.USD","LU0122379950.USD","BK4588","IE00BSNM7G36.USD","BK4566","IE00B7SZLL34.SGD","LU1037948541.HKD","LU2089984988.USD","LU2324357040.USD","BIB","BK4578","IE00B3T34201.USD","LU0109394709.USD","LU1934455194.USD","LU2357627491.SGD","BK4532","LU1037948897.HKD","IE00BZ1G4Q59.USD","LU0965509283.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667237756","title":"Gilead: Co & Paho Announce Partnership to Accelerate Access to Twice-Yearly Lenacapavir for Hiv Prevention Across Latin America & Caribbean","url":"https://stock-news.laohu8.com/highlight/detail?id=2667237756","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667237756?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nP8N3M60G8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1674673691.USD","LU1839511570.USD","SG9999015978.USD","LU2089984988.USD","IE00B19Z3B42.SGD","LU0965509101.SGD","LU1934455194.USD","LU2357627491.SGD","LU0058720904.USD","IE00BKVL7J92.USD","LU1061106388.HKD","GILD","LU1934455277.USD","BK4583","LU0965508806.USD","MEDI","BBH","LU0859254822.USD","LU1674673428.USD","SG9999015952.SGD","LU2468319806.SGD","TMED","LU1037948541.HKD","BIB","BMED","LU0289739699.SGD","LU0861579265.USD","BK4532","LU1066053197.SGD","LU1585245621.USD","LU0882574055.USD","BK4588","LU1057294990.SGD","TBXU","SG9999015945.SGD","IE0002270589.USD","LU0965509283.SGD","IE00B19Z3581.USD","IBBQ","IBB","LU0109394709.USD","SG9999015986.USD","LU1778281490.HKD","BK4568","BK4578","BK4550","LU0320765992.SGD","BK4585","IE00BZ1G4Q59.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667230916","title":"Gilead, PAHO Agree on HIV Prevention Drug Access in Latin America, Caribbean","url":"https://stock-news.laohu8.com/highlight/detail?id=2667230916","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667230916?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485000,"startTime":"0","endTime":"0","summary":"Gilead, PAHO agree on HIV prevention drug access in Latin America, CaribbeanSept 15 (Reuters)-U.S. drugmaker Gilead SciencesGILD.Osaid on Tuesday it had reached an agreement with the Pan American Heal","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL4N4570X0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU1023059063.AUD","IE00B19Z3581.USD","IE00BKVL7J92.USD","LU1778281490.HKD","IE00BSNM7G36.USD","LU0965509010.AUD","LU1839511570.USD","TBXU","MEDI","LU1430594728.SGD","BK4566","LU1061106388.HKD","LU2089984988.USD","LU2324357040.USD","IE0002270589.USD","LU0234570918.USD","LU0823416689.USD","IE00BZ1G4Q59.USD","LU0122379950.USD","LU1037948541.HKD","BK4568","LU0320765992.SGD","BBH","LU1674673691.USD","LU1674673428.USD","BK4583","IE00B7SZLL34.SGD","BK4585","SG9999015945.SGD","BIB","LU1037948897.HKD","IBBQ","IBB","TMED","BK4578","BK4532","LU2112291526.USD","LU0109394709.USD","LU1066053197.SGD","SG9999015986.USD","LU0114720955.EUR","SG9999015978.USD","LU2357627491.SGD","BMED","LU0289739699.SGD","LU0889565916.HKD","LU1571399168.USD","LU1934455863.HKD","GILD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667230686","title":"Gilead: to Continue Exploring Opportunities to Work with Paho to Support Country Readiness & Scale-up of Long-Acting Hiv Prevention Access","url":"https://stock-news.laohu8.com/highlight/detail?id=2667230686","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667230686?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nP8N3M60G8:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0859254822.USD","BK4588","LU1023059063.AUD","LU1778281490.HKD","LU1839511570.USD","LU0965509010.AUD","TBXU","LU0882574055.USD","MEDI","LU1430594728.SGD","IE00B3T34201.USD","BK4566","LU1585245621.USD","LU1061106388.HKD","LU2089984988.USD","LU2324357040.USD","IE0002270589.USD","LU0234570918.USD","LU0965509101.SGD","LU1037948541.HKD","LU0965509283.SGD","SG9999015952.SGD","BK4568","BBH","LU1066051498.USD","LU1674673691.USD","LU1674673428.USD","BK4583","IE00B7SZLL34.SGD","BK4585","SG9999015945.SGD","BIB","LU1037948897.HKD","IBBQ","IBB","BK4550","TMED","BK4578","LU0058720904.USD","BK4532","LU1066053197.SGD","SG9999015986.USD","LU0114720955.EUR","LU0861579265.USD","BMED","LU0289739699.SGD","LU1571399168.USD","LU1934455863.HKD","LU2468319806.SGD","GILD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667623244","title":"Gilead Exec Says Weekly Oral Hiv Prevention Drug Expected to Launch in First Quarter of 2027 - Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2667623244","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667623244?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:04","pubTimestamp":1789484692,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4570NU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1057294990.SGD","IBBQ","BK4550","LU1066053197.SGD","LU0122379950.USD","BK4588","LU0882574055.USD","LU1934455863.HKD","LU1674673428.USD","BMED","IBB","BBH","TMED","BK4568","GILD","IE0002270589.USD","SG9999015945.SGD","TBXU","LU0058720904.USD","BK4532","BK4566","LU0234570918.USD","LU2112291526.USD","SG9999015978.USD","LU0965509101.SGD","LU1037948897.HKD","SG9999015952.SGD","LU0965509283.SGD","LU1839511570.USD","BK4139","IE00BKVL7J92.USD","LU1037948541.HKD","LU1934455277.USD","BIB","LU0114720955.EUR","LU1430594728.SGD","LU0289739699.SGD","LU0965509010.AUD","LU1061106388.HKD","LU1066051498.USD","LU1585245621.USD","LU1674673691.USD","LU2324357040.USD","MEDI","IE00B7SZLL34.SGD","LU0859254822.USD","LU0889565916.HKD","IE00B19Z3581.USD","LU0320765992.SGD","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667462372","title":"Gilead Exec Says Hiv Market Growth Should Normalize to 2%-3% Within Next Couple of Quarters - Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2667462372","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667462372?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:04","pubTimestamp":1789484692,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4570NU:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BSNM7G36.USD","LU2324357040.USD","LU0889565916.HKD","IE00B3T34201.USD","LU0823416689.USD","LU0965508806.USD","LU1023059063.AUD","BK4139","BBH","LU2112291526.USD","SG9999015978.USD","LU1674673428.USD","LU1934455194.USD","BK4568","LU0882574055.USD","LU0114720955.EUR","LU0058720904.USD","IE00B19Z3B42.SGD","LU1057294990.SGD","SG9999015945.SGD","BK4550","LU2089984988.USD","MEDI","LU1585245621.USD","GILD","LU1934455277.USD","LU1934455863.HKD","LU0234570918.USD","LU1674673691.USD","LU1061106388.HKD","TMED","BIB","IE00B19Z3581.USD","LU1571399168.USD","LU0109394709.USD","IE00BZ1G4Q59.USD","LU0289739699.SGD","LU1430594728.SGD","IBBQ","LU0965509010.AUD","LU2357627491.SGD","TBXU","LU0122379950.USD","LU0965509101.SGD","IBB","BMED","LU1037948541.HKD","BK4578","LU0859254822.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667642502","title":"Amgen Announces Dividend of R$ 0.31 Per Unit, Payable Sept. 17","url":"https://stock-news.laohu8.com/highlight/detail?id=2667642502","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667642502?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:17","pubTimestamp":1789474653,"startTime":"0","endTime":"0","summary":"Amgen announces dividend of R$ 0.31 per unit, payable Sept. 17Amgen declared a Q3 2026 dividend of R$ 0.31 per unit on ISIN BRAMGNBDR004.Shares trade ex-dividend from Aug. 20, 2026; last day with enti","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nNDL9rWH4V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4534","BK4533","LU2089984988.USD","LU0868494617.USD","TBXU","LU0289739699.SGD","BK4581","IE00B2B36J28.USD","LU0122379950.USD","IBBQ","BBH","LU1061106388.HKD","LU1571399168.USD","LU0109394709.USD","BK4585","LU0320765992.SGD","LU2242646821.SGD","LU1023059063.AUD","LU2468319806.SGD","IE00BJT1NW94.SGD","LU1983299246.USD","LU0889565916.HKD","BK4139","IE0009355771.USD","IE00BJJMRZ35.SGD","PJP","LU2112291526.USD","SG9999001440.SGD","AMGN","PBE","IE0002141913.USD","LU2242652126.USD","IE00BFTCPJ56.SGD","IBB","BIB","BK4599","BK4566","IE00B4R5TH58.HKD","LU0058720904.USD","LU1057294990.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667444786","title":"Press Release: Legend Biotech Appoints Ingrid Zhang as Chief Executive Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2667444786","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667444786?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:00","pubTimestamp":1789473600,"startTime":"0","endTime":"0","summary":"BRIDGEWATER, N.J., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (\"Legend Biotech\" or the \"Company\"), a global leader in cell therapy, today announced that its Board of ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBT","R","BK4581","TBXU","BK4022","BK4232","IBBQ","IBB","BK4505","BK4139","GNOM","MEDI","BK4585","XBI","MEMS","CANC","LEGN","CNCR","SYNB","BK4588","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667644589","title":"Vertex Pharmaceuticals partners with Lindsey Vonn for JOURNAVX awareness","url":"https://stock-news.laohu8.com/highlight/detail?id=2667644589","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667644589?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:36","pubTimestamp":1789472175,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals (VRTX) has partnered with world champion skier Lindsey Vonn to raise awareness of JOURNAVX, a prescription non-opioid medici...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-partners-with-lindsey-vonn-for-journavx-awareness-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-partners-with-lindsey-vonn-for-journavx-awareness-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0566484027.USD","LU1559883803.SGD","LU2468319806.SGD","LU0109394709.USD","VERX","IDNA","LU2362541513.USD","BK4532","LU0061475181.USD","LU2362540622.SGD","TBXU","VRTX","SGXZ57979304.SGD","LU0256863811.USD","LU2362541273.HKD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","BK4023","IE0002141913.USD","IE00B19Z3B42.SGD","LU1430594728.SGD","LU0757428866.USD","LU2456880835.USD","BK4585","SG9999001176.SGD","BK4533","PBE","BBH","LU0823416689.USD","LU1674673691.USD","IBBQ","BK4588","GNMX","IE00BJJMRZ35.SGD","BIB","IE00BJT1NW94.SGD","IE00B19Z9Z06.USD","LU1585245621.USD","LU2237438978.USD","SG9999001176.USD","BK4567","LU1093756325.SGD","LU1035775433.USD","IBB","IE00B19Z9P08.USD","LU0234570918.USD","LU1069344957.HKD","LU1674673428.USD","SG9999013999.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667641173","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Centene (CNC), Natera (NTRA) and Vertex Pharmaceuticals (VRTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667641173","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667641173?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:20","pubTimestamp":1789471221,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Centene (CNC), Natera (NTRA) and Vertex Pharmaceut...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-centene-cnc-natera-ntra-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-centene-cnc-natera-ntra-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","LU0053671581.USD","HCSG","LU0234570918.USD","LU0823416689.USD","CNC","LU1988902786.USD","IBB","LU1035775433.USD","BIB","GNOM","IBBQ","BK4567","VRTX","HELX","LU1291159041.SGD","LU0012050646.USD","LU0648000940.SGD","XBI","LU0859254822.USD","BK4023","IE00B19Z3581.USD","IE00B19Z9Z06.USD","XLV","IDNA","NTRA","BK4154","LU2462157665.USD","LU1430594728.SGD","IE0002270589.USD","TBXU","LU0130518102.USD","LU2456880835.USD","BK4137","LU2065169927.USD","LU2065171311.SGD","LU0128526141.USD","LU2236285917.USD","CNCG","BK4581","BK4139","LU1585245621.USD","LU1674673691.USD","BK4585","LABU","BBH","PBE","LU0289739699.SGD","GNMX","VERX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}